论文部分内容阅读
目的:观察阳和汤联合CHOP方案治疗惰性淋巴瘤的临床疗效。方法:将60例惰性淋巴瘤患者随机分为两组,对照组单用CHOP方案化疗,治疗组在对照组化疗基础上联合阳和汤治疗。结果:总有效率治疗组为73.33%,对照组为53.33%,组间比较,差异有统计学意义(P<0.05)。治疗组消化道反应、骨髓抑制及肝肾功能损害等毒副作用较对照组均明显降低,组间比较,差异有统计学意义(P<0.05)。结论:阳和汤联合CHOP方案治疗惰性淋巴瘤疗效显著,安全性好。
Objective: To observe the clinical efficacy of Yanghe Decoction combined with CHOP regimen in the treatment of indolent lymphoma. Methods: Sixty patients with indolent lymphoma were randomly divided into two groups. The control group was treated with CHOP chemotherapy alone. The treatment group was treated with Yanghe Decoction on the basis of chemotherapy in the control group. Results: The total effective rate was 73.33% in the treatment group and 53.33% in the control group. There was significant difference between the two groups (P <0.05). In the treatment group, the side effects such as digestive tract reaction, bone marrow suppression and liver and kidney dysfunction were significantly lower than those in the control group. There was significant difference between the two groups (P <0.05). Conclusion: Yanghe Decoction combined with CHOP regimen has significant efficacy and safety in the treatment of indolent lymphoma.